Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IPHA Innate Pharma SA

交易中 07-01 13:45:47 EDT

1.86

+0.02

+1.09%

最高1.89	最低1.83	成交量5,820
今开1.86	昨收1.84	日振幅3.26%
总市值1.74亿	流通市值1.10亿	总股本9,372万
成交额1.07万	换手率0.01%	流通股本5,922万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IPHA","market":"US","secType":"STK","nameCN":"Innate Pharma SA","latestPrice":1.86,"timestamp":1782927863303,"preClose":1.84,"halted":0,"volume":5820,"delay":0,"changeRate":0.010869565217391313,"floatShares":59223966,"shares":93719323,"eps":-0.643951,"marketStatus":"交易中","change":0.02,"latestTime":"07-01 13:45:47 EDT","open":1.8563,"high":1.89,"low":1.83,"amount":10703.6784,"amplitude":0.032609,"askPrice":1.89,"askSize":126,"bidPrice":1.83,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.643951,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782936000000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1571284800000,"exchange":"NASDAQ","adjPreClose":1.84,"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.84,"latestTime":"16:00 EDT","volume":40,"amount":73.60000000000001,"timestamp":1782849601242,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.625584},"requestUrl":"/m/hq/s/IPHA","defaultTab":"news","newsList":[{"id":"2607098493","title":"Innate Pharma盘中异动 快速拉升5.62%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607098493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607098493?lang=zh_cn&edition=full","pubTime":"2026-01-30 00:10","pubTimestamp":1769703024,"startTime":"0","endTime":"0","summary":"北京时间2026年01月30日00时10分，Innate Pharma股票出现波动，股价快速上涨5.62%。截至发稿，该股报1.88美元/股，成交量7903股，换手率0.01%，振幅3.37%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.01%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130001024953efb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130001024953efb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517294332","title":"Innate Pharma盘中异动 急速拉升8.04%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294332?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185025,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Innate Pharma股票出现异动，股价急速拉升8.04%。截至发稿，该股报2.15美元/股，成交量1.1293万股，换手率0.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223025abe9b021&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223025abe9b021&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516530629","title":"Innate Pharma盘中异动 下午盘大幅下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516530629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516530629?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:04","pubTimestamp":1740773053,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时04分，Innate Pharma股票出现异动，股价大幅下挫5.32%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Camp4 Therapeutics Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3254.22%、592.00%、392.49%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010404139896c05c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010404139896c05c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386234","title":"Innate Pharma盘中异动 大幅拉升5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386234?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:54","pubTimestamp":1740668072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时54分，Innate Pharma股票出现异动，股价快速拉升5.31%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Quoin Pharmaceuticals Ltd、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为486.33%、98.25%、86.97%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biorestorative Therapies, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为59.93%、30.36%、21.99%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225432a2567fc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225432a2567fc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","BK4139","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514851092","title":"Innate Pharma盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851092?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580520,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分，Innate Pharma股票出现波动，股价急速拉升5.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Immunoprecise Antibodies Ltd.、Channel Therapeutics Corporation涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为129.63%、96.91%、79.81%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation，振幅分别为38.41%、17.13%、16.86%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223521abddedea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223521abddedea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514929090","title":"Innate Pharma盘中异动 早盘快速跳水6.32%报2.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514929090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514929090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:32","pubTimestamp":1740493952,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Innate Pharma股票出现异动，股价快速下挫6.32%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为751.55%、467.30%、235.08%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Maze Therapeutics, Inc.，振幅分别为20.51%、14.67%、8.87%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223232a2538724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223232a2538724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514773047","title":"Innate Pharma盘中异动 早盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514773047?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:02","pubTimestamp":1740412977,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时02分，Innate Pharma股票出现异动，股价大幅上涨5.36%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为237.75%、102.53%、31.18%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为162.04%、55.69%、53.34%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000257962eade6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000257962eade6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512993165","title":"Innate Pharma股价拉升21.13% 市值涨84.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512993165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512993165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:30","pubTimestamp":1739889048,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时30分，Innate Pharma股票出现波动，股价大幅上涨21.13%。截至发稿，该股报2.35美元/股，成交量839.128万股，换手率10.01%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223048abd3aeb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223048abd3aeb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509172720","title":"Innate Pharma盘中异动 下午盘急速下跌7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509172720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509172720?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:39","pubTimestamp":1738953592,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时39分，Innate Pharma股票出现异动，股价快速下跌7.00%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Nutriband Inc C/Wts 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为7935.83%、176.87%、126.48%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、54.97%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208023953a23d5758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208023953a23d5758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509726892","title":"Innate Pharma盘中异动 大幅拉升5.06%报2.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509726892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509726892?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:35","pubTimestamp":1738852556,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时35分，Innate Pharma股票出现波动，股价大幅上涨5.06%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为4192.52%、375.51%、118.10%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Celularity Inc C/Wts 16/07/2026 、Rani Therapeutics Holdings, Inc.，振幅分别为55.65%、27.95%、18.06%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223556987c8f95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223556987c8f95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508507894","title":"Innate Pharma盘中异动 急速拉升14.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508507894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508507894?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679469,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Innate Pharma股票出现异动，股价大幅上涨14.53%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Azitra Inc、Evaxion Biotech As、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为834.70%、673.24%、185.13%，振幅较大的相关个股有Omega Therapeutics, Inc.、Azitra Inc、Evaxion Biotech As，振幅分别为17.57%、13.82%、8.75%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223109abc227bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223109abc227bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508263341","title":"Innate Pharma盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508263341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508263341?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:27","pubTimestamp":1738603640,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时27分，Innate Pharma股票出现异动，股价快速下跌5.46%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为672.87%、519.86%、458.38%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、102.85%、63.94%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020401272096171597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020401272096171597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHA","IPHYF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507477185","title":"Innate Pharma盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507477185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507477185?lang=zh_cn&edition=full","pubTime":"2025-01-29 03:15","pubTimestamp":1738091745,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日03时15分，Innate Pharma股票出现异动，股价大幅下挫5.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Silexion Therapeutics Corp、Transcode Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Transcode Therapeutics, Inc.、Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为4895.49%、4890.67%、4291.30%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为239.72%、130.75%、122.16%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129031545a232a6db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129031545a232a6db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506330387","title":"Innate Pharma盘中异动 早盘急速拉升6.21%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506330387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506330387?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:31","pubTimestamp":1737988275,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时31分，Innate Pharma股票出现异动，股价急速上涨6.21%。截至发稿，该股报1.88美元/股，成交量27.5319万股，换手率0.33%，振幅0.00%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.01%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223115abba5f06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223115abba5f06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505861587","title":"Innate Pharma盘中异动 股价大涨5.90%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505861587?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:50","pubTimestamp":1737730242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时50分，Innate Pharma股票出现异动，股价快速上涨5.90%。截至发稿，该股报1.77美元/股，成交量3849股，换手率0.00%，振幅1.13%。Innate Pharma股票所在的生物技术行业中，整体跌幅为0.34%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242250429872063f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242250429872063f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","IPHA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505204227","title":"Innate Pharma盘中异动 下午盘股价大跌7.80%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505204227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505204227?lang=zh_cn&edition=full","pubTime":"2025-01-24 02:29","pubTimestamp":1737656997,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日02时29分，Innate Pharma股票出现异动，股价快速下跌7.80%。截至发稿，该股报1.63美元/股，成交量1.451万股，换手率0.02%，振幅2.26%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.96%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240229589870e561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240229589870e561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHA","IPHYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503624794","title":"Innate Pharma盘中异动 临近午盘大幅跳水5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503624794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503624794?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:38","pubTimestamp":1736959124,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时38分，Innate Pharma股票出现异动，股价快速跳水5.88%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Aditxt, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为210.92%、173.30%、171.79%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、63.21%、61.60%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116003844a2231ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116003844a2231ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IPHYF","BK4139","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503891955","title":"Innate Pharma盘中异动 早盘快速拉升5.08%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503891955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503891955?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:17","pubTimestamp":1736781460,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时17分，Innate Pharma股票出现波动，股价大幅上涨5.08%。Innate Pharma股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为8022.13%、3888.97%、411.78%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.，振幅分别为318.93%、124.54%、106.07%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323174096025c43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011323174096025c43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502705180","title":"Innate Pharma盘中异动 股价大跌5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705180","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502705180?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:40","pubTimestamp":1736358012,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时40分，Innate Pharma股票出现波动，股价快速下挫5.91%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3448.63%、599.47%、588.81%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为192.73%、143.11%、89.00%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109014012aba37509&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109014012aba37509&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500614089","title":"Innate Pharma盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500614089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500614089?lang=zh_cn&edition=full","pubTime":"2025-01-01 00:11","pubTimestamp":1735661516,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日00时11分，Innate Pharma股票出现异动，股价快速下挫5.13%。截至发稿，该股报1.85美元/股，成交量5759股，换手率0.01%，振幅3.85%。Innate Pharma股票所在的生物技术行业中，整体涨幅为0.19%。Innate Pharma公司简介：Innate Pharma SA是一家处于临床试验阶段的生物技术公司，致力于开发针对癌症患者的免疫治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010011569856a5bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501010011569856a5bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IPHYF","IPHA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innate-pharma.com/fr","stockEarnings":[{"period":"1week","weight":-0.0265},{"period":"1month","weight":0.0055},{"period":"3month","weight":0.363},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.0138},{"period":"ytd","weight":0.0514}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":-0.0128},{"period":"3month","weight":0.1397},{"period":"6month","weight":0.0951},{"period":"1year","weight":0.2087},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innate Pharma S.A.成立于1999年9月23日。该公司是一家临床阶段的生物技术公司，为癌症患者开发免疫疗法。凭借其在抗体工程和创新靶点识别方面的专业知识，该公司正在开发创新和差异化的下一代抗体疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.022541},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.022389},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.051036},{"month":4,"riseRate":0.571429,"avgChangeRate":0.027233},{"month":5,"riseRate":0.285714,"avgChangeRate":0.019988},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.071644},{"month":7,"riseRate":0.666667,"avgChangeRate":0.050981},{"month":8,"riseRate":0.666667,"avgChangeRate":0.006631},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.030037},{"month":10,"riseRate":0.5,"avgChangeRate":-0.003161},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.013747},{"month":12,"riseRate":0.571429,"avgChangeRate":0.100532}],"exchange":"NASDAQ","name":"Innate Pharma SA","nameEN":"Innate Pharma SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innate Pharma SA,IPHA,Innate Pharma SA股票,Innate Pharma SA股票老虎,Innate Pharma SA股票老虎国际,Innate Pharma SA行情,Innate Pharma SA股票行情,Innate Pharma SA股价,Innate Pharma SA股市,Innate Pharma SA股票价格,Innate Pharma SA股票交易,Innate Pharma SA股票购买,Innate Pharma SA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innate Pharma SA(IPHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innate Pharma SA(IPHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}